Overall, the overexpression of YTHDF2 may simultaneously accelerate the degradation of UBXN1, LXRα, and HIVEP2 mRNAs, promoting glioma development through a complex network of actions. The gene discussed is HIVEP2; the disease is central nervous system cancer.